(Q53542332)
Statements
Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction. (English)
Chao Liu
Yue Fan
Lu Zhou
Hong-Yi Zhu
Yi-Chen Song
Liang Hu
Yu Wang
Qing-Ping Li
1 April 2015
188
22-32